GSM5034682: AML3 Response sample after 3 cycles of nivolumab; Homo sapiens; RNA-Seq
Ficoll density centrifugation and bead-based dead cell removal droplet-based scRNA-seq (5' scRNA-seq) using the chromium platform (10x Genomics); surface marker staining using Total-seq C antibodies
GEO Accession
GSM5034682